These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 3668358)
1. Development of a radioimmunoassay for quantitating prethrombin 2 in human plasma. Conway EM; Lau HK; Bauer KA; Rosenberg RD J Lab Clin Med; 1987 Nov; 110(5):567-75. PubMed ID: 3668358 [TBL] [Abstract][Full Text] [Related]
2. Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life. Takahashi I; Kato K; Sugiura I; Takamatsu J; Kamiya T; Saito H J Lab Clin Med; 1991 Oct; 118(4):317-25. PubMed ID: 1940573 [TBL] [Abstract][Full Text] [Related]
3. [Use of affinity chromatography for isolating prethrombin 1]. Strukova SM; Mitroshina TN; Umarova VA; Kudriashov BA Vopr Med Khim; 1981; 27(6):840-4. PubMed ID: 7336661 [TBL] [Abstract][Full Text] [Related]
4. [Activation by heparin-Sepharose of prothrombin conversion to prethrombin 1]. Strukova SM; Mitroshina TN; Kudriashov BA Biokhimiia; 1981 May; 46(5):904-10. PubMed ID: 7295815 [TBL] [Abstract][Full Text] [Related]
5. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Pelzer H; Schwarz A; Stüber W Thromb Haemost; 1991 Feb; 65(2):153-9. PubMed ID: 2053101 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of an enzyme-linked immunosorbent assay for the determination of prothrombin fragment F1.2 (Dade Prothrombin Fragment F1.2 ELISA: Baxter Diagnostics Inc., U.S.A.) using micro-titer plate]. Suzuki T; Amano K; Kuroso K; Fukutake K; Fujimaki M Rinsho Byori; 1993 Feb; 41(2):215-9. PubMed ID: 8361024 [TBL] [Abstract][Full Text] [Related]
7. The turnover in normal dogs of prothrombin and its fragments; effect of induced intravascular coagulation. Owen CA; Mann KG; McDuffie FC Thromb Haemost; 1979 Aug; 42(2):548-55. PubMed ID: 505363 [TBL] [Abstract][Full Text] [Related]
8. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism. Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013 [TBL] [Abstract][Full Text] [Related]
9. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex. Teitel JM; Bauer KA; Lau HK; Rosenberg RD Blood; 1982 May; 59(5):1086-97. PubMed ID: 7074214 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation. Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212 [TBL] [Abstract][Full Text] [Related]
11. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma. Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455 [TBL] [Abstract][Full Text] [Related]
12. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency. Bauer KA; Goodman TL; Kass BL; Rosenberg RD J Clin Invest; 1985 Aug; 76(2):826-36. PubMed ID: 3875633 [TBL] [Abstract][Full Text] [Related]
13. Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency. Ingerslev J; Holm M; Christiansen K; Knudsen L; Négrier C Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S129-34. PubMed ID: 9819044 [TBL] [Abstract][Full Text] [Related]
14. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation. Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398 [TBL] [Abstract][Full Text] [Related]
15. High molecular weight forms of antithrombin III complexes in blood. Marciniak E; Gora-Maslak G Thromb Haemost; 1983 Feb; 49(1):32-6. PubMed ID: 6845270 [TBL] [Abstract][Full Text] [Related]
16. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Levi M; Toh CH; Thachil J; Watson HG Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477 [TBL] [Abstract][Full Text] [Related]
17. Detection of protein C activation in humans. Bauer KA; Kass BL; Beeler DL; Rosenberg RD J Clin Invest; 1984 Dec; 74(6):2033-41. PubMed ID: 6549015 [TBL] [Abstract][Full Text] [Related]
18. Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer. Gadducci A; Marrai R; Baicchi U; Gagetti O; Facchini V; Genazzani AR Gynecol Oncol; 1996 May; 61(2):215-7. PubMed ID: 8626135 [TBL] [Abstract][Full Text] [Related]
19. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis. Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840 [TBL] [Abstract][Full Text] [Related]
20. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation. Tran TH; Duckert F Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]